Feed 600671.SS
60
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
600671.SS · SHH
¥21.70 -3.38% (-¥0.76)
1M +7.75%
Market Cap ¥2.6B
P/E Ratio 161.68x
Div. Yield -
ROE 23.94%
Bulios Fair Price
¥14.22
34.5% downside
Current Price
¥21.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 600671.SS is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive P/B 35.80x
P/S 12.96x
P/E 161.68x
Growth
100 /100
Growing Rev. growth 24.60%
FCF growth N/A
Book val. growth N/A
Profitability
37 /100
Moderate FCF margin 13.77%
Op. margin 5.22%
Gross margin 48.37%
Quality
44 /100
Average Asset turnover 0.44x
ROA 3.52%
ROIC 2.00%
Debt
15 /100
High Net debt/EBITDA 4.84x
Int. coverage 2.43x
Debt/Equity 2.53x
Stability
9 /100
Unstable Profitable years 2
EPS volatility 69.49%
Beta 0.01x
Ask StockBot about 600671.SS
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Xuejian Sun
Employees
392
Headquarters
Hangzhou